Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000225727 | SCV000112481 | likely benign | not specified | 2016-11-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000225727 | SCV000168176 | benign | not specified | 2014-03-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000206025 | SCV000261315 | benign | Duchenne muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000999379 | SCV001155966 | benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | DMD: BS1, BS2 |
ARUP Laboratories, |
RCV000999379 | SCV002047863 | benign | not provided | 2020-10-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537358 | SCV004749568 | benign | DMD-related disorder | 2019-07-19 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |